Systematic review and meta-analysis links benzene exposure to increased lymphoid neoplasm risk
Benzene exposure linked to higher lymphoid neoplasm risk in large review
This systematic review and meta-analysis evaluated 95 human studies on benzene exposure across occupational and environmental settings. The …
A review of 95 studies shows benzene exposure is associated with a significantly higher risk of lymphoid neoplasms, including Hodgkin lympho…
Review of AI models shows high accuracy for ovarian cancer diagnosis and outcome prediction
Artificial intelligence models outperform traditional methods for ovarian cancer diagnosis
This review synthesizes evidence on artificial intelligence and machine learning models for ovarian cancer. The authors note these tools dem…
A review found AI models showed high accuracy in diagnosing ovarian cancer and predicting patient outcomes, potentially improving care.
FDA Approves Herceptin (trastuzumab) for HER2-Overexpressing Breast and Gastric Cancers
FDA approves Herceptin for certain breast and stomach cancers.
The FDA approved Herceptin (trastuzumab) for the treatment of HER2-overexpressing breast cancer (adjuvant and metastatic) and HER2-overexpre…
The FDA approved Herceptin (trastuzumab) for HER2-positive breast cancer and stomach cancer. It targets tumors with high levels of HER2 prot…
FDA Approves Phesgo (pertuzumab, trastuzumab, hyaluronidase) for HER2-Positive Breast Cancer
FDA approves new shot for HER2 positive breast cancer treatment
The FDA approved Phesgo, a fixed-dose combination of pertuzumab, trastuzumab, and hyaluronidase for subcutaneous injection, for HER2-positiv…
The FDA approved Phesgo, a new shot for HER2 positive breast cancer. It treats early and metastatic breast cancer. This gives patients a fas…
FDA Approves Herceptin Hylecta (trastuzumab/hyaluronidase) for HER2+ Breast Cancer
FDA approves new shot for HER2 positive breast cancer treatment
FDA approved Herceptin Hylecta, a subcutaneous formulation of trastuzumab with hyaluronidase, for adjuvant and metastatic HER2-overexpressin…
The FDA approved Herceptin Hylecta, a shot for HER2 positive breast cancer. It is given under the skin in minutes instead of an IV drip. Thi…
Systematic Review Maps Exponential Growth of Antibody-Drug Conjugate Trials in Lung Cancer
Global review shows antibody-drug conjugates for lung cancer trials are growing fast
This systematic review of 466 global trials documents exponential growth in antibody-drug conjugate (ADC) trials for lung cancer, from 1 in …
A global review of lung cancer trials shows antibody-drug conjugate research is expanding rapidly, with more than 100 new trials registered …
Meta-analysis links emotional distress to worse outcomes in advanced lung cancer
Emotional distress linked to worse lung cancer survival
This systematic review and meta-analysis of 911 patients with advanced NSCLC found emotional distress was significantly associated with redu…
For people with advanced lung cancer, feeling emotionally distressed is tied to lower survival and worse treatment response, a new analysis …
Meta-analysis shows bevacizumab plus FOLFOX improves response rates without increasing common toxicities in advanced colorectal cancer
Adding bevacizumab to standard chemo improves tumor response in advanced colorectal cancer
This systematic review and meta-analysis evaluated bevacizumab combined with FOLFOX versus FOLFOX alone in patients with advanced or metasta…
A large review found that adding bevacizumab to standard chemotherapy improves how well tumors respond and keeps disease under control longe…
Systematic review and meta-analysis links higher prognostic nutritional index to better survival in non-small cell lung cancer
Higher nutrition scores linked to longer life after lung cancer surgery
This systematic review and meta-analysis evaluated the prognostic nutritional index (PNI) in patients with non-small cell lung cancer underg…
A look at 11 studies shows that a simple nutrition score predicts better survival for people having lung cancer surgery.
Systematic review of immune checkpoint inhibitors in cancer efficacy and safety
Immune Checkpoint Inhibitors Show Promise For Cancer Patients With High Tumor Burden
This systematic review synthesizes evidence from 15 randomized trials and cohort studies on immune checkpoint inhibitors in cancer. It finds…
A review of trials suggests immune checkpoint inhibitors work well for some cancer patients but carry risks like skin rashes and organ infla…
Network meta-analysis compares therapies for liver metastatic uveal melanoma
Liver-directed therapy combined with ICIs leads for metastatic uveal melanoma survival
This systematic review and network meta-analysis synthesized evidence on therapeutic modalities for patients with liver metastatic uveal mel…
A network meta-analysis of 2,585 patients found liver-directed therapy combined with immune checkpoint inhibitors offered the best survival …
Systematic review and meta-analysis of DDS-based chemotherapy in murine colon cancer models
Targeted drug delivery shrinks colon cancer tumors in mice by over half
This systematic review and meta-analysis evaluates DDS-based chemotherapy in murine models of colon cancer. The analysis pooled data from 53…
A new analysis of mouse studies shows targeted drug delivery systems significantly reduce colon cancer tumor growth compared to standard tre…